Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Basic information
- Product Name:
- Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
- Synonyms:
-
- Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
- N4-Benzoyl-5’-O-(4,4’-dimethoxy trityl)-2’-O,4’-C-methylene-cytidine 3’-O-[(2-cyanoethyl) (N,N-diisopropyl)]-phosphorramidite
- DMTr-LNA-C(Bz)-3-CED-phosphoramidite
- N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylene-cytidine?3’-O-[(2-cyanoethyl)?(N,N-diisopropyl)]-phosphoramidite
- DMTr-L-C(Bz)-3-CED-phosphoramidite
- N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
- DMT-2’-0-4’-C-Locked-C(Bz)-Phosphoramidite
- N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzam
- CAS:
- 206055-78-9
- MF:
- C47H52N5O9P
- MW:
- 861.93
- Mol File:
- 206055-78-9.mol
More
Less
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Chemical Properties
- pka
- 8.57±0.20(Predicted)
More
Less
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Usage And Synthesis
Uses
DMTr-LNA-C(Bz)-3-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)Supplier
Nanjing Baifuli Technology Co., Ltd.
- Tel
- 25-25-58740604 15951658055
- sales@unisyn.cn
Zhengzhou Granlen Sciences, ltd.
- Tel
- 0371-85513397 +86-18610099868
- info@granlen.com
NewCan Biotech Limited
- Tel
- +86-0571-86912261 +8613735419629
- sales@newcanbio.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Beijing Qinling Pharmaceutical Co., Ltd.
- Tel
- 010-61241352 18901327973
- 834537306@qq.com